US EditionA Controversial U.S. Study of Hepatitis B Vaccines Will Continue in Africa, HHS says
The trial targets 14,000 newborns to study short-term health effects, despite concerns about withholding vaccines in a high-prevalence Hepatitis B country.
4 Articles
4 Articles
The study, conducted by a Danish team and funded by the United States, planned to deprive 7,000 newborns of a dose of vaccine to protect them from the risks of cirrhosis and liver cancer.
Trump Administration Says It's Not Canceling Tuskegee-Style Medical Study That Will Withhold Hepatitis Vaccine From Newborns
What do you get when you put a vaccine conspiracy theorist in charge of the agency responsible for funding medical research throughout the globe? A recipe for Tuskegee 2.0, it seems. Some bombshell reporting over the last month has revealed a monstrous plan by Robert F Kennedy Jr.’s Department of Health and Human Services to fund a $1.6 million study on hepatitis B vaccines among 14,000 newborns in the West African country of Guinea-Bissau. As p…
Confusion Over 'Cancellation' Of Controversial Hepatitis B Trial In Guinea-Bissau
A controversial clinical trial on the effects of the hepatitis B vaccine on babies in Guinea-Bissau has been “cancelled”, according to Dr Yap Boum of Africa Centres for Disease Control and Prevention (CDC). However, this has been contested by the US Department of Health and Human Services (HHS), which is funding a Danish group to […]
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
